Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Health & MedicineOne-Off1aManifold MarketsSem KYCDados de resolução verificadosRazoavelmente calibradoPrevisão da comunidade atualNão 77.9%
Previsores
14
Tipo de pergunta
binary
Metodologia
Play-money forecasting platform
Tipo de fonte
Previsão
Dados do mercado
Atualizado há 12 horas
Desatualizado21/02/23, 20:23 UTC31/12/27, 22:59 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Will FDA approve any mRNA vaccine against any type of human papillomavirus infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiWill the FDA approve a cure for Type 1 diabetes before 2033?
KalshiFDA approves skin cancer vaccine by which date?
PolymarketRegras
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Mercados abertos
Health & MedicinePOLYMARKETEbola pandemic in 2026?
- No+1.1pt97%
- Yes-1.1pt3%
- Volume total
- € 650,1 mil
- Volume 24h
- € 29,7 mil
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 20,5 mil
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volume total
- € 1,6 mi
- Volume 24h
- € 5,2 mil
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt64%
- September+2.0pt41%
- June28%
- Volume total
POLYMARKETNew pandemic in 2026?
- No93.1%
- Yes6.9%
- Volume total
- € 915,1 mil
- Volume 24h
- € 3,2 mil
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before 2027+8.0pt84%
- before April 202781%
- before December+1.0pt69%
+3 mais resultados
- Volume total
- € 14,2 mil
- Measles cases in 2026?
- New pandemic before 2028?
- Ebola pandemic in 2026?
- Will the FDA approve any psychedelic substance for medical use this year?
- Measles cases in U.S. in 2026?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA approves Retatrutide this year?
- Which countries will report an Ebola case in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Which countries will have an Ebola case in 2026?
Perguntas frequentes
- Quais são as probabilidades atuais de Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028??
- A Manifold Markets cota No em 78% em 8 de setembro de 2026.
- Quando Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? é resolvido?
- Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? deverá ser resolvido em 31 de dezembro de 2027.
- Como Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? é liquidado?
- A Manifold Markets liquida este mercado da seguinte forma: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.